Blood test could replace risky needle for prenatal genetic diagnosis
NCT ID NCT06147414
First seen Jan 22, 2026 · Last updated Jun 22, 2026 · Updated 26 times
Summary
This study is testing a new blood test that can diagnose single-gene disorders in unborn babies using a sample from the mother. The test looks at fetal DNA found in the mother's blood, which is safer than traditional invasive methods that carry a small risk of miscarriage. Researchers aim to enroll 550 pregnant women to see how accurate the test is for conditions like sickle cell disease, cystic fibrosis, and muscular dystrophy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Cochin, Maternité Port-Royal, service de Gynécologie obstétrique
RECRUITINGParis, 75014, France
Contact Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
blood sample
What this could lead to
If successful, this could replace invasive prenatal tests with a simple blood draw, reducing miscarriage risk and enabling earlier diagnosis for many genetic conditions.
What could go wrong
The test is still being validated and may not work for all families or conditions. Inconclusive results are possible, and the approach is complex and not yet widely available.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.